Glucotrack executed multiple financing agreements to strengthen liquidity. The company added $3.5 million of senior secured convertible notes in a Bridge Follow-On with associated warrants, featuring an 8% coupon and a 22% original issue discount, with conversion and exercisability subject to stockholder approval. It also closed a $2.0 million Interim PIPE, issuing pre-funded warrants (no expiry) and five-year common warrants at $1.50 per share, subject to ownership limits. A companion Registration Rights Agreement will register the resale of shares underlying the PIPE warrants, enhancing investor liquidity and supporting future capital access.
Agreement 1: Glucotrack Adds $3.5M Follow-On Bridge Notes With Warrants to Bolster Liquidity
- Agreement type: Senior secured convertible notes and warrants (Bridge Follow-On)
- Counterparty: New Investors
- Signed / Effective: Aug 04 2026 / same
- Duration / Termination: Matures Apr 14 2027
- Reason: Extend bridge financing and bolster liquidity
Agreement 2: Glucotrack Raises $2.0M via Interim PIPE With Pre-Funded and Common Warrants
- Agreement type: Private placement of pre-funded and common warrants (Interim PIPE)
- Counterparty: PIPE Purchaser
- Signed / Effective: Aug 04 2026 / same
- Duration / Termination: Pre-funded: no expiry; Common: 5 years
- Reason: Raise interim capital with equity-linked securities
Agreement 3: Glucotrack Grants Registration Rights to PIPE Investor for Resale of Warrant Shares
- Agreement type: Registration rights agreement for PIPE securities
- Counterparty: PIPE Purchaser
- Signed / Effective: Aug 04 2026 / same
- Duration / Termination: At will
- Reason: Provide resale registration for investor
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.